Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Nature Reviews. Drug Discovery|June 16, 2018
The promise and challenges of immune agonist antibody development in cancerPatrick A Mayes, Kenneth W Hance, Axel HoosMutation Research|May 13, 2005
Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccinesKenneth W Hance, Hasan E Zeytin, John W GreinerAmerican Journal of Physiology. Gastrointestinal and Liver Physiology|August 16, 2002
Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell linesJames C Fleet, Faria Eksir, Kenneth W Hance, et al.Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Combination of physical activity, nutrition, or other metabolic factors and vaccine responseKenneth W Hance, Connie J Rogers, Stephen D Hursting, et al.Journal of Cellular Biochemistry|September 9, 2006
Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2Anna Klopot, Kenneth W Hance, Sara Peleg, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Intratumoral immunotherapy of established solid tumors with chitosan/IL-12David A Zaharoff, Kenneth W Hance, Connie J Rogers, et al.Vaccine|January 30, 2007
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccinationDavid A Zaharoff, Connie J Rogers, Kenneth W Hance, et al.Breast Disease|June 1, 2006
Epidemiology of inflammatory breast cancer (IBC)William F Anderson, Catherine Schairer, Bingshu E Chen, et al.Vaccine|November 27, 2007
Chitosan solution enhances the immunoadjuvant properties of GM-CSFDavid A Zaharoff, Connie J Rogers, Kenneth W Hance, et al.Journal of the National Cancer Institute|July 7, 2005
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer InstituteKenneth W Hance, William F Anderson, Susan S Devesa, et al.Pageof 3